OBJECTIVE: To determine the population-based incidence of hypertensive diseases in pregnancy in Western New York. METHODS: A database of 77,358 women with singleton pregnancies was analyzed using birth certificate data. The incidence of pregnancies complicated by gestational hypertension, preeclampsia, and eclampsia was determined. RESULTS: The overall incidence of pregnancy-associated hypertensive disease varied slightly from 1999 to 2003. The incidence of preeclampsia decreased from 1.8% to 1.1% (p < 0.01). This decrease persisted over time, despite controlling for known risk factors, such as body mass index, age, ethnicity, parity, smoking, diabetes, and chronic hypertension. CONCLUSION: The incidence of pregnancy-related hypertensive disorders slightly decreased in our population in the last 5 years, with a decline in the rate of preeclampsia accounting for this change. Further analysis may provide additional insights into the population-based incidence of preeclampsia.
OBJECTIVE: To determine the population-based incidence of hypertensive diseases in pregnancy in Western New York. METHODS: A database of 77,358 women with singleton pregnancies was analyzed using birth certificate data. The incidence of pregnancies complicated by gestational hypertension, preeclampsia, and eclampsia was determined. RESULTS: The overall incidence of pregnancy-associated hypertensive disease varied slightly from 1999 to 2003. The incidence of preeclampsia decreased from 1.8% to 1.1% (p < 0.01). This decrease persisted over time, despite controlling for known risk factors, such as body mass index, age, ethnicity, parity, smoking, diabetes, and chronic hypertension. CONCLUSION: The incidence of pregnancy-related hypertensive disorders slightly decreased in our population in the last 5 years, with a decline in the rate of preeclampsia accounting for this change. Further analysis may provide additional insights into the population-based incidence of preeclampsia.
Authors: Vesna D Garovic; Wendy M White; Lisa Vaughan; Mie Saiki; Santosh Parashuram; Oscar Garcia-Valencia; Tracey L Weissgerber; Natasa Milic; Amy Weaver; Michelle M Mielke Journal: J Am Coll Cardiol Date: 2020-05-12 Impact factor: 24.094
Authors: Allison L Naleway; Stephanie A Irving; Michelle L Henninger; De-Kun Li; Pat Shifflett; Sarah Ball; Jennifer L Williams; Janet Cragan; Julianne Gee; Mark G Thompson Journal: Vaccine Date: 2014-04-14 Impact factor: 3.641
Authors: Christine L Roberts; Jane B Ford; Charles S Algert; Sussie Antonsen; James Chalmers; Sven Cnattingius; Manjusha Gokhale; Milton Kotelchuck; Kari K Melve; Amanda Langridge; Carole Morris; Jonathan M Morris; Natasha Nassar; Jane E Norman; John Norrie; Henrik Toft Sørensen; Robin Walker; Christopher J Weir Journal: BMJ Open Date: 2011-05-24 Impact factor: 2.692
Authors: Hawawu Hussein; Mansour Shamsipour; Masud Yunesian; Mohammad Sadegh Hassanvand; Abraham Assan; Akbar Fotouhi Journal: Iran J Public Health Date: 2021-06 Impact factor: 1.429
Authors: Christine L Roberts; Jane C Bell; Jane B Ford; Ruth M Hadfield; Charles S Algert; Jonathan M Morris Journal: Hypertens Pregnancy Date: 2008 Impact factor: 2.108